InspireMD Inc (NYSEAMERICAN:NSPR) saw a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 177,306 shares, a growth of 60.7% from the February 15th total of 110,307 shares. Based on an average daily trading volume, of 585,137 shares, the short-interest ratio is presently 0.3 days. Approximately 2.5% of the shares of the company are sold short.

Shares of InspireMD (NYSEAMERICAN NSPR) opened at $2.58 on Friday. InspireMD has a 12-month low of $2.19 and a 12-month high of $45.15. The company has a market capitalization of $7.04, a price-to-earnings ratio of -0.15 and a beta of 2.61.

InspireMD (NYSEAMERICAN:NSPR) last released its quarterly earnings data on Wednesday, February 14th. The medical equipment provider reported ($7.38) EPS for the quarter. InspireMD had a negative net margin of 179.74% and a negative return on equity of 720.33%. The business had revenue of $0.83 million for the quarter.

TRADEMARK VIOLATION WARNING: “InspireMD Inc (NSPR) Short Interest Update” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another site, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The legal version of this story can be viewed at

InspireMD Company Profile

InspireMD, Inc is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures.

Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with's FREE daily email newsletter.